423 related articles for article (PubMed ID: 31365879)
21. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
22. Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy.
Wang L; Hu Y; Hao Y; Li L; Zheng C; Zhao H; Niu M; Yin Y; Zhang Z; Zhang Y
J Control Release; 2018 Sep; 286():74-84. PubMed ID: 30026078
[TBL] [Abstract][Full Text] [Related]
23. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
24. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Leung MHM; Shen AQ
Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247
[TBL] [Abstract][Full Text] [Related]
25. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
26. Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.
Zhang M; He J; Zhang W; Liu J
Pharm Res; 2018 Aug; 35(11):199. PubMed ID: 30167890
[TBL] [Abstract][Full Text] [Related]
27. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
28. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
29. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
[TBL] [Abstract][Full Text] [Related]
30. Development of electrosprayed artesunate-loaded core-shell nanoparticles.
Ho HN; Laidmäe I; Kogermann K; Lust A; Meos A; Nguyen CN; Heinämäki J
Drug Dev Ind Pharm; 2017 Jul; 43(7):1134-1142. PubMed ID: 28277847
[TBL] [Abstract][Full Text] [Related]
31. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
[TBL] [Abstract][Full Text] [Related]
32. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells.
Paka GD; Ramassamy C
Mol Pharm; 2017 Jan; 14(1):93-106. PubMed ID: 27744707
[TBL] [Abstract][Full Text] [Related]
33. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
34. Core-shell microencapsulation of curcumin in PLGA microparticles: programmed for application in ovarian cancer therapy.
Dwivedi P; Yuan S; Han S; Mangrio FA; Zhu Z; Lei F; Ming Z; Cheng L; Liu Z; Si T; Xu RX
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S481-S491. PubMed ID: 30299174
[TBL] [Abstract][Full Text] [Related]
35. Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release.
Yuan S; Lei F; Liu Z; Tong Q; Si T; Xu RX
PLoS One; 2015; 10(7):e0132609. PubMed ID: 26208167
[TBL] [Abstract][Full Text] [Related]
36. Development and optimization of a novel PLGA-Levan based drug delivery system for curcumin, using a quality-by-design approach.
Bahadori F; Eskandari Z; Ebrahimi N; Bostan MS; Eroğlu MS; Oner ET
Eur J Pharm Sci; 2019 Oct; 138():105037. PubMed ID: 31394257
[TBL] [Abstract][Full Text] [Related]
37. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
[TBL] [Abstract][Full Text] [Related]
38. Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480.
Sufi SA; Hoda M; Pajaniradje S; Mukherjee V; Coumar SM; Rajagopalan R
Int J Pharm; 2020 Oct; 588():119738. PubMed ID: 32777534
[TBL] [Abstract][Full Text] [Related]
39. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
40. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
